Showing results (61-70 of 348) with videos related to
Sort By:
Pageof 35
The American Journal of Pathology|August 26, 2003
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoterShereen Ezzat, Shunjiang Yu, Sylvia L AsaEndocrine Pathology|April 12, 2023
The Unique Importance of Differentiation and Function in Endocrine NeoplasiaSylvia L Asa, Silvia Uccella, Arthur TischlerAnnals of Surgical Oncology|December 2, 2009
Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extensionOzgur Mete, Lorne Rotstein, Sylvia L AsaMolecular and Cellular Endocrinology|September 19, 2017
The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitaryZhongyi Shen, Sylvia L Asa, Shereen EzzatMolecular and Cellular Endocrinology|November 6, 2016
Ikaros and its interacting partner CtBP target the metalloprotease ADAMTS10 to modulate pituitary cell functionZhongyi Shen, Sylvia L Asa, Shereen EzzatEndocrinology and Metabolism Clinics of North America|May 27, 2008
Epigenetic dysregulation in thyroid neoplasiaTetsuo Kondo, Sylvia L Asa, Shereen EzzatThe American Journal of Surgical Pathology|February 28, 2008
Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumorsRunjan Chetty, Stefano Serra, Sylvia L AsaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasiaXuegong Zhu, Sylvia L Asa, Shereen EzzatJournal of Molecular Endocrinology|July 24, 2012
Biomarkers of aggressive pituitary adenomasOzgur Mete, Shereen Ezzat, Sylvia L AsaEndocrine Pathology|May 11, 2018
Immunohistochemical Biomarkers in Thyroid PathologyZubair Baloch, Ozgur Mete, Sylvia L AsaPageof 35